Condition: Chemotherapy Induced Neuropathic Pain · Chemotherapy Induced Pain Neuropathy · Chemotherapy Induced Pain · Sponsor: Dogwood Therapeutics Inc.
A randomized study to determine safety and efficacy of a series of subcutaneous (SC) injections of HAL in patients with CINP, compared to matching placebo injections. After that, subjects may have the option to enter an Open Label extension phase, where available, in which all subjects will receive Halneuron.
This description comes directly from the study's public registry record.
Dogwood Therapeutics · 866-620-9255 · Mehran@dwtx.com
Always discuss trial participation with your own doctor first.
| Central Recruiting Site | Sheffield, Alabama, United States | Recruiting |
| Central Recruiting Site | Glendale, Arizona, United States | Recruiting |
| Central Recruiting Site | Phoenix, Arizona, United States | Recruiting |
| Central Recruiting Site | Fair Oaks, California, United States | Recruiting |
| Central Recruiting Site | Fountain Valley, California, United States | Recruiting |
| Central Recruiting Site | Los Angeles, California, United States | Recruiting |
| Central Recruiting Site | Santa Rosa, California, United States | Recruiting |
| Central Recruiting Site | Wheat Ridge, Colorado, United States | Recruiting |
| Central Recruiting Site | Jacksonville, Florida, United States | Recruiting |
| Central Recruiting Site | Jacksonville, Florida, United States | Recruiting |
| Central Recruiting Site | Lakeland, Florida, United States | Recruiting |
| Central Recruiting Site | Orlando, Florida, United States | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06848348